Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Medical Regulation topic
No spam. Unsubscribe anytime.
Board of Pharmacy urges clearer state rules for med‑spas after rise in complaints
Summary
The Board of Pharmacy told lawmakers Nevada lacks a statutory definition of 'med‑spa' and oversight is fragmented across multiple boards, resulting in consumer complaints about counterfeit drugs, improper storage and unqualified operators; the board asked for modest statutory standards and clearer enforcement authority.
A Board of Pharmacy official told the Health and Human Services committee on March 31 that Nevada needs clearer statutory guidance to protect consumers who use medical‑spa services.
Dave Reese, executive secretary for the Board of Pharmacy, said the state lacks a legal definition of “med‑spa” in statute and that complaints have risen in recent years—ranging from counterfeit or mis‑sourced medication to bloodborne contamination and untrained personnel running procedures in non‑medical settings. Where licensed physicians and APRNs practice in standard medical settings, Reese said problems are rare; the complaints cluster around unlicensed facilities and non‑medical operators administering drugs.
Reese told the panel the state has a patchwork of oversight: the cosmetology board covers certain aesthetic procedures, the Board of Pharmacy handles drug possession and distribution questions, and the Board of Medical Examiners or nursing boards may regulate clinical practice—leaving enforcement gaps. Allison Jenco Herzog (Nevada Health Authority) told the panel HCQC currently lacks authority to regulate med‑spas and would need legislative authority and staff to do so.
Why it matters: Lawmakers pressed how to reduce a “whack‑a‑mole” problem where enforcement actions temporarily close sites that reappear elsewhere. Members debated whether the state should create a new licensing pathway or strengthen standards and inter‑board cooperation. Reese suggested focused statutory standards, improved interagency enforcement and targeted inspection authority rather than a sweeping ban.
Several lawmakers noted past legislation that folded some med‑spa oversight into the cosmetology board, but said resourcing for inspections is a barrier. Reese and panelists said some combination of clearer statutory definitions, minimum safety and staffing standards, and better coordination among boards (and with the Health Authority) would reduce public harms and make reporting clearer for consumers.
The committee did not vote; members asked staff to consider drafting options that clarify roles, strengthen reporting and consider enforcement resources.
